VAXELIS
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
63361-243 -
Package NDC
63361-243-15 -
Application number
BLA125563 -
SPL ID
899b15fd-89c2-44ab-95c8-a457ea7cf0be
What the source publishes
- Labeler
- MSP Vaccine Company
- Active ingredients
- diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine
- Form
- INJECTION, SUSPENSION
- Routes
- INTRAMUSCULAR
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- VACCINE
Names this record is found by
- VAXELIS
- diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine
- CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
- CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
- BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED)
- BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
- BORDETELLA PERTUSSIS PERTACTIN ANTIGEN
- BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN
- POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)
- POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)
- POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
- HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN
- HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN
Complete source data
{
"name": "VAXELIS",
"splId": "899b15fd-89c2-44ab-95c8-a457ea7cf0be",
"labels": [],
"routes": [
"INTRAMUSCULAR"
],
"labeler": "MSP Vaccine Company",
"finished": true,
"packaging": [
{
"sample": false,
"description": "10 SYRINGE in 1 PACKAGE (63361-243-15) / .5 mL in 1 SYRINGE (63361-243-88)",
"package_ndc": "63361-243-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20181221"
}
],
"productId": "63361-243_899b15fd-89c2-44ab-95c8-a457ea7cf0be",
"useDomain": "unknown",
"dosageForm": "INJECTION, SUSPENSION",
"productNdc": "63361-243",
"deaSchedule": null,
"genericName": "diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine",
"productType": "VACCINE",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)",
"strength": "15 [Lf]/.5mL"
},
{
"name": "CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)",
"strength": "5 [Lf]/.5mL"
},
{
"name": "BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED)",
"strength": "20 ug/.5mL"
},
{
"name": "BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)",
"strength": "20 ug/.5mL"
},
{
"name": "BORDETELLA PERTUSSIS PERTACTIN ANTIGEN",
"strength": "3 ug/.5mL"
},
{
"name": "BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN",
"strength": "5 ug/.5mL"
},
{
"name": "POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)",
"strength": "29 [D'ag'U]/.5mL"
},
{
"name": "POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)",
"strength": "7 [D'ag'U]/.5mL"
},
{
"name": "POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)",
"strength": "26 [D'ag'U]/.5mL"
},
{
"name": "HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN",
"strength": "10 ug/.5mL"
},
{
"name": "HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN",
"strength": "3 ug/.5mL"
}
],
"applicationNumber": "BLA125563",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20181221",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "unknown",
"harmonizedIdentifiers": {},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:63361-243_899b15fd-89c2-44ab-95c8-a457ea7cf0be"